Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mauricio Tohen, Dr.P.H., M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R29MH051948 (TOHEN, MAURICIO F.) Aug 1, 1995 - Jul 31, 2000
    NIH/NIMH
    LONGITUDINAL STUDY OF FIRST EPISODE MANIA
    Role: Principal Investigator
  2. R03MH048444 (TOHEN, MAURICIO F.) Sep 30, 1991 - Aug 31, 1994
    NIH/NIMH
    PREDICTORS OF OUTCOME AFTER A FIRST-EPISODE OF PSYCHOSIS
    Role: Principal Investigator
  3. P01MH031154 (HOLZMAN, PHILIP S) Aug 1, 1977 - Dec 31, 2003
    NIH/NIMH
    BIOLOGICAL RESEARCH IN SCHIZOPHRENIA
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Köhler-Forsberg O, Sylvia LG, Ruberto VL, Kuperberg M, Shannon AP, Fung V, Overhage L, Calabrese JR, Thase M, Bowden CL, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Iosifescu DV, McElroy S, Ostacher MJ, Nierenberg AA. Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. J Affect Disord. 2020 May 16; 273:131-137. PMID: 32421593.
    Citations:    
  2. Bustillo JR, Upston J, Mayer EG, Jones T, Maudsley AA, Gasparovic C, Tohen M, Lenroot R. Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study. Neuropsychopharmacology. 2020 May 13. PMID: 32403117.
    Citations:    
  3. Fountoulakis KN, Yatham LN, Grunze H, Vieta E, Young AH, Blier P, Tohen M, Kasper S, Moeller HJ. The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder. Int J Neuropsychopharmacol. 2020 Apr 23; 23(4):230-256. PMID: 31802122.
    Citations:    
  4. Miller J, Atala R, Sarangarm D, Tohen M, Sharma S, Bhatt S, Khafaja M, Kroth PJ, Cruz M. Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big Data. Community Ment Health J. 2020 Jul; 56(5):959-962. PMID: 31997123.
    Citations:    
  5. Caroff SN, Citrome L, Meyer J, Sajatovic M, Goldberg JF, Jain R, Lundt L, Lindenmayer JP, McEvoy JP, McIntyre RS, Tohen M, Ketter TA. A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia. J Clin Psychiatry. 2020 Jan 28; 81(2). PMID: 31995677.
    Citations:    
  6. Nestsiarovich A, Kerner B, Mazurie AJ, Cannon DC, Hurwitz NG, Zhu Y, Nelson SJ, Oprea TI, Crisanti AS, Tohen M, Perkins DJ, Lambert CG. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder. Psychoneuroendocrinology. 2020 02; 112:104511. PMID: 31744781.
    Citations:    
  7. Earley WR, Burgess MV, Khan B, Rekeda L, Suppes T, Tohen M, Calabrese JR. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study. Bipolar Disord. 2019 Oct 18. PMID: 31628698.
    Citations:    
  8. Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MHJ, Pfennig A, Post RM, Preisig M, Ratheesh A, Salvatore P, Tohen M, Vázquez GH, Vieta E, Yatham LN, Youngstrom EA, Van Meter A, Correll CU. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disord. 2019 12; 21(8):720-740. PMID: 31479581.
    Citations:    
  9. Kamali M, Reilly-Harrington NA, Chang WC, McInnis M, McElroy SL, Ketter TA, Shelton RC, Deckersbach T, Tohen M, Kocsis JH, Calabrese JR, Gao K, Thase ME, Bowden CL, Kinrys G, Bobo WV, Brody BD, Sylvia LG, Rabideau DJ, Nierenberg AA. Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. J Affect Disord. 2019 12 01; 259:164-172. PMID: 31445343.
    Citations:    
  10. Fung VC, Overhage LN, Sylvia LG, Reilly-Harrington NA, Kamali M, Gao K, Shelton RC, Ketter TA, Bobo WV, Thase ME, Calabrese JR, Tohen M, Deckersbach T, Nierenberg AA. Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors. J Affect Disord. 2019 10 01; 257:17-22. PMID: 31299400.
    Citations:    
  11. Kerner B, Crisanti AS, DeShaw JL, Ho JG, Jordan K, Krall RL, Kuntz MJ, Mazurie AJ, Nestsiarovich A, Perkins DJ, Schroeter QL, Smith AN, Tohen M, Volesky E, Zhu Y, Lambert CG. Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study. JMIR Ment Health. 2019 Jun 25; 6(6):e12848. PMID: 31237566.
    Citations:    
  12. Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord. 2019 08; 21(5):394-409. PMID: 31112628.
    Citations:    
  13. Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatr. 2019 Aug; 31(4):230-234. PMID: 31169098.
    Citations:    
  14. Abbott CC, Miller J, Lloyd M, Tohen M. Electroconvulsive therapy electrode placement for bipolar state-related targeted engagement. Int J Bipolar Disord. 2019 May 04; 7(1):11. PMID: 31053985.
    Citations:    
  15. Chen M, Fitzgerald HM, Madera JJ, Tohen M. Functional outcome assessment in bipolar disorder: A systematic literature review. Bipolar Disord. 2019 05; 21(3):194-214. PMID: 30887632.
    Citations:    
  16. Nestsiarovich A, Kerner B, Mazurie AJ, Cannon DC, Hurwitz NG, Zhu Y, Nelson SJ, Oprea TI, Unruh ML, Crisanti AS, Tohen M, Perkins DJ, Lambert CG. Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy. J Affect Disord. 2019 06 01; 252:201-211. PMID: 30986735.
    Citations:    
  17. Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019 03 01; 246:126-131. PMID: 30580198.
    Citations:    Fields:    
  18. Behrendt-Møller I, Madsen T, Sørensen HJ, Sylvia L, Friedman ES, Shelton RC, Bowden CL, Calabrese JR, McElroy SL, Ketter TA, Reilly-Harrington NA, Gao K, Thase M, V Bobo W, Tohen M, McInnis M, Kamali M, Kocsis JH, Deckersbach T, Köhler-Forsberg O, Nierenberg AA. Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder. Bipolar Disord. 2019 06; 21(4):350-360. PMID: 30383333.
    Citations:    Fields:    
  19. Yaramala SR, McElroy SL, Geske J, Winham S, Gao K, Reilly-Harrington NA, Ketter TA, Deckersbach T, Kinrys G, Kamali M, Sylvia LG, McInnis MG, Friedman ES, Thase ME, Kocsis JH, Tohen M, Calabrese JR, Bowden CL, Shelton RC, Nierenberg AA, Bobo WV. The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. J Affect Disord. 2020 Apr 01; 266:772-781. PMID: 30241956.
    Citations: 1     Fields:    
  20. Khalsa HK, Baldessarini RJ, Tohen M, Salvatore P. Aggression among 216 patients with a first-psychotic episode of bipolar I disorder. Int J Bipolar Disord. 2018 Aug 11; 6(1):18. PMID: 30097737.
    Citations:    
  21. Nestsiarovich A, Mazurie AJ, Hurwitz NG, Kerner B, Nelson SJ, Crisanti AS, Tohen M, Krall RL, Perkins DJ, Lambert CG. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders. Bipolar Disord. 2018 12; 20(8):761-771. PMID: 29920885.
    Citations:    Fields:    
  22. Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y. Can a Framework Be Established for the Safe Use of Ketamine? Am J Psychiatry. 2018 07 01; 175(7):587-589. PMID: 29656666.
    Citations: 1     Fields:    
  23. Gonzalez R, Suppes T, Zeitzer J, McClung C, Tamminga C, Tohen M, Forero A, Dwivedi A, Alvarado A. The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study. Int J Bipolar Disord. 2018 Feb 19; 6(1):5. PMID: 29457195.
    Citations: 1     
  24. Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, Birmaher B, Tohen M, Suppes T. Early Intervention in Bipolar Disorder. Am J Psychiatry. 2018 05 01; 175(5):411-426. PMID: 29361850.
    Citations: 1     Fields:    
  25. Tohen M. Severity of symptoms in mania-clinical guidelines and study design implications. Bipolar Disord. 2018 03; 20(2):171-172. PMID: 29327798.
    Citations:    Fields:    Translation:Humans
  26. Caldieraro MA, Dufour S, Sylvia LG, Gao K, Ketter TA, Bobo WV, Walsh S, Janos J, Tohen M, Reilly-Harrington NA, McElroy SL, Shelton RC, Bowden CL, Deckersbach T, Nierenberg AA. Treatment outcomes of acute bipolar depressive episode with psychosis. Depress Anxiety. 2018 05; 35(5):402-410. PMID: 29329498.
    Citations:    Fields:    Translation:Humans
  27. Gonzalez R, Tohen M. Circadian Rhythm and the Prediction of Relapse in Bipolar Disorder. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 29286594.
    Citations:    Fields:    
  28. Köhler-Forsberg O, Sylvia L, Deckersbach T, Ostacher MJ, McInnis M, Iosifescu D, Bowden C, McElroy S, Calabrese J, Thase M, Shelton RC, Tohen M, Kocsis J, Friedman E, Ketter T, Nierenberg AA. Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatr. 2018 Oct; 30(5):297-305. PMID: 29212563.
    Citations:    Fields:    Translation:HumansCells
  29. Caldieraro MA, Walsh S, Deckersbach T, Bobo WV, Gao K, Ketter TA, Shelton RC, Reilly-Harrington NA, Tohen M, Calabrese JR, Thase ME, Kocsis JH, Sylvia LG, Nierenberg AA. Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression. Aust N Z J Psychiatry. 2018 10; 52(10):994-1002. PMID: 29143534.
    Citations:    Fields:    
  30. Xiao L, Ganocy SJ, Findling RL, Chang K, DelBello MP, Kane JM, Tohen M, Xiang YT, Correll CU. Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1158-e1166. PMID: 28922591.
    Citations:    Fields:    
  31. Nestsiarovich A, Hurwitz NG, Nelson SJ, Crisanti AS, Kerner B, Kuntz MJ, Smith AN, Volesky E, Schroeter QL, DeShaw JL, Young SS, Obenchain RL, Krall RL, Jordan K, Fawcett J, Tohen M, Perkins DJ, Lambert CG. Systemic challenges in bipolar disorder management: A patient-centered approach. Bipolar Disord. 2017 12; 19(8):676-688. PMID: 28901625.
    Citations: 1     Fields:    Translation:Humans
  32. Tohen M. The need to change from a phenomenological to a target engagement approach. Bipolar Disord. 2017 09; 19(6):513-514. PMID: 28892289.
    Citations:    Fields:    
  33. Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington N, Bobo WV, Kocsis JH, McInnis MG, Bowden CL, Ketter TA, Friedman ES, Shelton RC, McElroy SL, Gao K, Rabideau DJ, Nierenberg AA. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord. 2018 01 01; 225:563-568. PMID: 28881294.
    Citations:    Fields:    Translation:Humans
  34. Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG. Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. J Affect Disord. 2018 01 01; 225:775-777. PMID: 28826887.
    Citations:    Fields:    
  35. Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA. Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. J Affect Disord. 2017 12 01; 223:146-152. PMID: 28755622.
    Citations: 1     Fields:    Translation:Humans
  36. Rosenbaum N, Tinney DM, Tohen M. Collaboration to Reduce Tragedy and Improve Outcomes: Law Enforcement, Psychiatry, and People Living With Mental Illness. Am J Psychiatry. 2017 Jun 01; 174(6):513-517. PMID: 28565948.
    Citations:    Fields:    Translation:Humans
  37. Tohen M, Ng-Mak D, Rajagopalan K, Halpern R, Chuang CC, Loebel A. Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States. Prim Care Companion CNS Disord. 2017 Jun 01; 19(3). PMID: 28590601.
    Citations:    Fields:    Translation:Humans
  38. Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG. Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. J Affect Disord. 2017 08 01; 217:183-189. PMID: 28411507.
    Citations:    Fields:    Translation:Humans
  39. Caldieraro MA, Sylvia LG, Dufour S, Walsh S, Janos J, Rabideau DJ, Kamali M, McInnis MG, Bobo WV, Friedman ES, Gao K, Tohen M, Reilly-Harrington NA, Ketter TA, Calabrese JR, McElroy SL, Thase ME, Shelton RC, Bowden CL, Kocsis JH, Deckersbach T, Nierenberg AA. Clinical correlates of acute bipolar depressive episode with psychosis. J Affect Disord. 2017 08 01; 217:29-33. PMID: 28365478.
    Citations: 1     Fields:    Translation:Humans
  40. Tohen M. Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design. Int J Neuropsychopharmacol. 2017 02 01; 20(2):95-97. PMID: 28927197.
    Citations:    Fields:    Translation:Humans
  41. Köhler-Forsberg O, Sylvia L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy S, Shelton RC, Nierenberg AA. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder. Depress Anxiety. 2017 03; 34(3):281-290. PMID: 28135023.
    Citations: 1     Fields:    Translation:Humans
  42. Russell R, Metraux D, Tohen M. Cultural influences on suicide in Japan. Psychiatry Clin Neurosci. 2017 Jan; 71(1):2-5. PMID: 27487762.
    Citations:    Fields:    Translation:Humans
  43. Machado-Vieira R, Luckenbaugh DA, Ballard ED, Henter ID, Tohen M, Suppes T, Zarate CA. Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study. Am J Psychiatry. 2017 Jan 01; 174(1):70-76. PMID: 27523498.
    Citations: 2     Fields:    Translation:Humans
  44. Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust N Z J Psychiatry. 2017 Apr; 51(4):355-365. PMID: 27126391.
    Citations: 1     Fields:    Translation:Humans
  45. Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA. Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. J Affect Disord. 2016 Nov 15; 205:159-164. PMID: 27449548.
    Citations:    Fields:    Translation:Humans
  46. Tohen M, Khalsa HM, Salvatore P, Zarate CA, Strakowski SM, Sanchez-Toledo JP, Baldessarini RJ. The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses. J Clin Psychiatry. 2016 06; 77(6):781-8. PMID: 27232651.
    Citations:    Fields:    Translation:Humans
  47. Ballard ED, Vande Voort JL, Luckenbaugh DA, Machado-Vieira R, Tohen M, Zarate CA. Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study. Bipolar Disord. 2016 06; 18(4):363-72. PMID: 27233466.
    Citations: 3     Fields:    Translation:Humans
  48. Malhi GS, Byrow Y, Cassidy F, Cipriani A, Demyttenaere K, Frye MA, Gitlin M, Kennedy SH, Ketter TA, Lam RW, McShane R, Mitchell AJ, Ostacher MJ, Rizvi SJ, Thase ME, Tohen M. Ketamine: stimulating antidepressant treatment? BJPsych Open. 2016 May; 2(3):e5-e9. PMID: 27703782.
    Citations: 1     
  49. Lambert CG, Mazurie AJ, Lauve NR, Hurwitz NG, Young SS, Obenchain RL, Hengartner NW, Perkins DJ, Tohen M, Kerner B. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort. Bipolar Disord. 2016 05; 18(3):247-60. PMID: 27226264.
    Citations: 3     Fields:    Translation:Humans
  50. Tohen M, Mintz J, Bowden CL. Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi-state Outcome Analysis of Treatments (MOAT). Bipolar Disord. 2016 05; 18(3):282-7. PMID: 27027886.
    Citations: 1     Fields:    Translation:Humans
  51. Tohen M. In memoriam--Vivek Singh. J Affect Disord. 2016 Mar 15; 193:144. PMID: 27265910.
    Citations:    Fields:    
  52. Michalak EE, Jones S, Lobban F, Algorta GP, Barnes SJ, Berk L, Berk M, Hole R, Lapsley S, Maxwell V, Milev R, McManamy J, Murray G, Tohen M, Tse S, Sanchez de Carmona M, Johnson SL. Harnessing the potential of community-based participatory research approaches in bipolar disorder. Int J Bipolar Disord. 2016 Dec; 4(1):4. PMID: 26856996.
    Citations: 2     
  53. Deckersbach T, Nierenberg AA, McInnis MG, Salcedo S, Bernstein EE, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, Bobo WV, Friedman ES, Singh V, Tohen M, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Reilly-Harrington NA, Rabideau DJ, Kinrys G, Kamali M. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. J Clin Psychiatry. 2016 Jan; 77(1):100-8. PMID: 26845265.
    Citations: 2     Fields:    Translation:Humans
  54. Nierenberg AA, McElroy SL, Friedman ES, Ketter TA, Shelton RC, Deckersbach T, McInnis MG, Bowden CL, Tohen M, Kocsis JH, Calabrese JR, Kinrys G, Bobo WV, Singh V, Kamali M, Kemp D, Brody B, Reilly-Harrington NA, Sylvia LG, Shesler LW, Bernstein EE, Schoenfeld D, Rabideau DJ, Leon AC, Faraone S, Thase ME. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016 Jan; 77(1):90-9. PMID: 26845264.
    Citations: 6     Fields:    Translation:Humans
  55. Reilly-Harrington NA, Shelton RC, Kamali M, Rabideau DJ, Shesler LW, Trivedi MH, McElroy SL, Sylvia LG, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Bobo WV, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Gold AK, Singh V, Finkelstein DM, Kinrys G, Nierenberg AA. A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. J Affect Disord. 2016 Mar 01; 192:212-8. PMID: 26748736.
    Citations: 1     Fields:    Translation:Humans
  56. Tohen M. Psychotropic agents and the prediction of weight gain. J Clin Psychiatry. 2015 Nov; 76(11):e1474-5. PMID: 26646044.
    Citations:    Fields:    Translation:Humans
  57. Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. Am J Psychiatry. 2015 Oct; 172(10):950-66. PMID: 26423481.
    Citations: 71     Fields:    Translation: